The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anticoccidial Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Coccidiosis is an infection of the intestinal tract of animals which is caused by coccidia protozoa. The disease is characterized by invasion of the intestinal wall by the protozoa. Coccidia undergo several stages of growth and multiplication. Coccidia damages mucosal and submucosal tissues of the intestinal tract. The disease is especially prevalent when animals and birds are grouped together in significant numbers by their infected feces and tissues. Coccidia infect a wide variety of animals, such as poultry species, cattle, sheep and pigs and can cause devastating lose in meat production.
The global Anticoccidial Drugs market size is expected to reach US$ 1403 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoccidial Drugs in various end use industries. The expanding demands from the Poultry, Swine, Fish and Cattle, are propelling Anticoccidial Drugs market. Antibiotic Anticoccidials, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ionophore Anticoccidials segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoccidial Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoccidial Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoccidial Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoccidial Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoccidial Drugs covered in this report include Merial, Novartis Animal Healthcare, Ceva Santé Animale, Boehringer Ingelheim, Virbac, Zoetis, Biopredic, Intas and Dosch Pharma, etc.
The global Anticoccidial Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merial
Novartis Animal Healthcare
Ceva Santé Animale
Boehringer Ingelheim
Virbac
Zoetis
Biopredic
Intas
Dosch Pharma
Jurox
Global Anticoccidial Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoccidial Drugs market, Segment by Type:
Antibiotic Anticoccidials
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
Global Anticoccidial Drugs market, by Application
Poultry
Swine
Fish
Cattle
Companion Animals
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anticoccidial Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anticoccidial Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Coccidiosis is an infection of the intestinal tract of animals which is caused by coccidia protozoa. The disease is characterized by invasion of the intestinal wall by the protozoa. Coccidia undergo several stages of growth and multiplication. Coccidia damages mucosal and submucosal tissues of the intestinal tract. The disease is especially prevalent when animals and birds are grouped together in significant numbers by their infected feces and tissues. Coccidia infect a wide variety of animals, such as poultry species, cattle, sheep and pigs and can cause devastating lose in meat production.
The global Anticoccidial Drugs market size is expected to reach US$ 1403 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoccidial Drugs in various end use industries. The expanding demands from the Poultry, Swine, Fish and Cattle, are propelling Anticoccidial Drugs market. Antibiotic Anticoccidials, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ionophore Anticoccidials segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoccidial Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoccidial Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoccidial Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoccidial Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoccidial Drugs covered in this report include Merial, Novartis Animal Healthcare, Ceva Santé Animale, Boehringer Ingelheim, Virbac, Zoetis, Biopredic, Intas and Dosch Pharma, etc.
The global Anticoccidial Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merial
Novartis Animal Healthcare
Ceva Santé Animale
Boehringer Ingelheim
Virbac
Zoetis
Biopredic
Intas
Dosch Pharma
Jurox
Global Anticoccidial Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoccidial Drugs market, Segment by Type:
Antibiotic Anticoccidials
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
Global Anticoccidial Drugs market, by Application
Poultry
Swine
Fish
Cattle
Companion Animals
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anticoccidial Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anticoccidial Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Anticoccidial Drugs Market Overview
1.1 Anticoccidial Drugs Product Overview
1.2 Anticoccidial Drugs Market Segment by Type
1.2.1 Antibiotic Anticoccidials
1.2.2 Ionophore Anticoccidials
1.2.3 Chemical Derivative Anticoccidials
1.3 Global Anticoccidial Drugs Market Size by Type
1.3.1 Global Anticoccidial Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Anticoccidial Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anticoccidial Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anticoccidial Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anticoccidial Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anticoccidial Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anticoccidial Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anticoccidial Drugs Sales Breakdown by Type (2018-2023)
2 Global Anticoccidial Drugs Market Competition by Company
2.1 Global Top Players by Anticoccidial Drugs Sales (2018-2023)
2.2 Global Top Players by Anticoccidial Drugs Revenue (2018-2023)
2.3 Global Top Players by Anticoccidial Drugs Price (2018-2023)
2.4 Global Top Manufacturers Anticoccidial Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anticoccidial Drugs Market Competitive Situation and Trends
2.5.1 Anticoccidial Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anticoccidial Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoccidial Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anticoccidial Drugs Market
2.8 Key Manufacturers Anticoccidial Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anticoccidial Drugs Status and Outlook by Region
3.1 Global Anticoccidial Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anticoccidial Drugs Historic Market Size by Region
3.2.1 Global Anticoccidial Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Anticoccidial Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Anticoccidial Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anticoccidial Drugs Forecasted Market Size by Region
3.3.1 Global Anticoccidial Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Anticoccidial Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Anticoccidial Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anticoccidial Drugs by Application
4.1 Anticoccidial Drugs Market Segment by Application
4.1.1 Poultry
4.1.2 Swine
4.1.3 Fish
4.1.4 Cattle
4.1.5 Companion Animals
4.2 Global Anticoccidial Drugs Market Size by Application
4.2.1 Global Anticoccidial Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Anticoccidial Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anticoccidial Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anticoccidial Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anticoccidial Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anticoccidial Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anticoccidial Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anticoccidial Drugs Sales Breakdown by Application (2018-2023)
5 North America Anticoccidial Drugs by Country
5.1 North America Anticoccidial Drugs Historic Market Size by Country
5.1.1 North America Anticoccidial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anticoccidial Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Anticoccidial Drugs Sales in Value by Country (2018-2023)
5.2 North America Anticoccidial Drugs Forecasted Market Size by Country
5.2.1 North America Anticoccidial Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Anticoccidial Drugs Sales in Value by Country (2024-2029)
6 Europe Anticoccidial Drugs by Country
6.1 Europe Anticoccidial Drugs Historic Market Size by Country
6.1.1 Europe Anticoccidial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anticoccidial Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Anticoccidial Drugs Sales in Value by Country (2018-2023)
6.2 Europe Anticoccidial Drugs Forecasted Market Size by Country
6.2.1 Europe Anticoccidial Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Anticoccidial Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Anticoccidial Drugs by Region
7.1 Asia-Pacific Anticoccidial Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anticoccidial Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anticoccidial Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anticoccidial Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anticoccidial Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anticoccidial Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anticoccidial Drugs Sales in Value by Region (2024-2029)
8 Latin America Anticoccidial Drugs by Country
8.1 Latin America Anticoccidial Drugs Historic Market Size by Country
8.1.1 Latin America Anticoccidial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anticoccidial Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anticoccidial Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Anticoccidial Drugs Forecasted Market Size by Country
8.2.1 Latin America Anticoccidial Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anticoccidial Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Anticoccidial Drugs by Country
9.1 Middle East and Africa Anticoccidial Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anticoccidial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anticoccidial Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anticoccidial Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anticoccidial Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anticoccidial Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anticoccidial Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merial
10.1.1 Merial Company Information
10.1.2 Merial Introduction and Business Overview
10.1.3 Merial Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merial Anticoccidial Drugs Products Offered
10.1.5 Merial Recent Development
10.2 Novartis Animal Healthcare
10.2.1 Novartis Animal Healthcare Company Information
10.2.2 Novartis Animal Healthcare Introduction and Business Overview
10.2.3 Novartis Animal Healthcare Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Animal Healthcare Anticoccidial Drugs Products Offered
10.2.5 Novartis Animal Healthcare Recent Development
10.3 Ceva Santé Animale
10.3.1 Ceva Santé Animale Company Information
10.3.2 Ceva Santé Animale Introduction and Business Overview
10.3.3 Ceva Santé Animale Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ceva Santé Animale Anticoccidial Drugs Products Offered
10.3.5 Ceva Santé Animale Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boehringer Ingelheim Anticoccidial Drugs Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Virbac
10.5.1 Virbac Company Information
10.5.2 Virbac Introduction and Business Overview
10.5.3 Virbac Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Virbac Anticoccidial Drugs Products Offered
10.5.5 Virbac Recent Development
10.6 Zoetis
10.6.1 Zoetis Company Information
10.6.2 Zoetis Introduction and Business Overview
10.6.3 Zoetis Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Zoetis Anticoccidial Drugs Products Offered
10.6.5 Zoetis Recent Development
10.7 Biopredic
10.7.1 Biopredic Company Information
10.7.2 Biopredic Introduction and Business Overview
10.7.3 Biopredic Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biopredic Anticoccidial Drugs Products Offered
10.7.5 Biopredic Recent Development
10.8 Intas
10.8.1 Intas Company Information
10.8.2 Intas Introduction and Business Overview
10.8.3 Intas Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Intas Anticoccidial Drugs Products Offered
10.8.5 Intas Recent Development
10.9 Dosch Pharma
10.9.1 Dosch Pharma Company Information
10.9.2 Dosch Pharma Introduction and Business Overview
10.9.3 Dosch Pharma Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Dosch Pharma Anticoccidial Drugs Products Offered
10.9.5 Dosch Pharma Recent Development
10.10 Jurox
10.10.1 Jurox Company Information
10.10.2 Jurox Introduction and Business Overview
10.10.3 Jurox Anticoccidial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Jurox Anticoccidial Drugs Products Offered
10.10.5 Jurox Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anticoccidial Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anticoccidial Drugs Industrial Chain Analysis
11.4 Anticoccidial Drugs Market Dynamics
11.4.1 Anticoccidial Drugs Industry Trends
11.4.2 Anticoccidial Drugs Market Drivers
11.4.3 Anticoccidial Drugs Market Challenges
11.4.4 Anticoccidial Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anticoccidial Drugs Distributors
12.3 Anticoccidial Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
